Arm: right franchise, wrong point in the capex cycle
No argument with the business. The entry is the problem: the multiple already discounts two more years of a capex cycle that has historically run three.
Discussion · 9
Useful framing. The utilisation assumption is where I disagree. How much does this depend on the macro cooperating?
This changed my mind. The elasticity decay across the price actions is the tell. Does the thesis survive a soft guide next quarter?
Been long since the last one. The elasticity decay across the price actions is the tell. Does the thesis survive a soft guide next quarter?
Good piece. The mix argument is the part I had not considered properly. How are you thinking about the timing risk here?
Reading this against my own model. The utilisation assumption is where I disagree. Where does this break if rates back up another 50bp?
Good piece. The margin bridge is doing more work here than is acknowledged. Is there a cleaner way to express this than the equity?
I hold the other side of this. The channel data is what makes this hard to dismiss. Interested in what the kill switch looks like in practice.
That is the right objection. Rates hit the multiple rather than the earnings path. A 50bp move costs perhaps two turns and does not touch the thesis.
Strong piece, one objection. The distinction between adequate reserves and the earnings path is well made. Would you underwrite this without the catalyst date?